Repligen Corporation to Present at Upcoming May Investor Conferences
Repligen Corporation (NASDAQ:RGEN), a bioprocessing technology leader in life sciences, has announced its participation in two major investor conferences in May 2025. The company's Chief Financial Officer, Jason K. Garland, will represent Repligen at:
1. RBC Capital Markets' 2025 Global Healthcare Conference in New York (May 20-21), featuring an analyst-led discussion on May 20 at 3:35 p.m. ET
2. Craig-Hallum's 22nd Annual Institutional Investor Conference in Minneapolis (May 28)
Both events will include one-on-one meetings with investors. The RBC conference presentation will be available via live webcast on Repligen's Investor Relations website.
Repligen Corporation (NASDAQ:RGEN), leader nelle tecnologie di bioprocessing nel settore delle scienze della vita, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel maggio 2025. Il Direttore Finanziario della società, Jason K. Garland, rappresenterà Repligen in:
1. RBC Capital Markets' 2025 Global Healthcare Conference a New York (20-21 maggio), con una discussione guidata da analisti il 20 maggio alle 15:35 ET
2. Craig-Hallum's 22nd Annual Institutional Investor Conference a Minneapolis (28 maggio)
Entrambi gli eventi includeranno incontri individuali con gli investitori. La presentazione alla conferenza RBC sarà disponibile in diretta streaming sul sito web delle Relazioni con gli Investitori di Repligen.
Repligen Corporation (NASDAQ:RGEN), líder en tecnología de bioprocesamiento en ciencias de la vida, ha anunciado su participación en dos importantes conferencias para inversores en mayo de 2025. El Director Financiero de la empresa, Jason K. Garland, representará a Repligen en:
1. RBC Capital Markets' 2025 Global Healthcare Conference en Nueva York (20-21 de mayo), con una discusión dirigida por analistas el 20 de mayo a las 3:35 p.m. ET
2. Craig-Hallum's 22nd Annual Institutional Investor Conference en Minneapolis (28 de mayo)
Ambos eventos incluirán reuniones individuales con inversores. La presentación en la conferencia de RBC estará disponible en transmisión en vivo en el sitio web de Relaciones con Inversores de Repligen.
Repligen Corporation (NASDAQ:RGEN)은 생명과학 분야의 바이오프로세싱 기술 선도기업으로, 2025년 5월 두 개의 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사의 최고재무책임자 Jason K. Garland가 Repligen을 대표하여 다음 행사에 참석합니다:
1. RBC Capital Markets 2025 글로벌 헬스케어 컨퍼런스 (뉴욕, 5월 20-21일), 5월 20일 오후 3시 35분(동부시간)에 애널리스트 주도 토론 진행
2. Craig-Hallum 22번째 연례 기관 투자자 컨퍼런스 (미니애폴리스, 5월 28일)
두 행사 모두 투자자와의 일대일 미팅이 포함됩니다. RBC 컨퍼런스 발표는 Repligen 투자자 관계 웹사이트를 통해 실시간 웹캐스트로 제공될 예정입니다.
Repligen Corporation (NASDAQ:RGEN), leader en technologies de bioprocédés dans les sciences de la vie, a annoncé sa participation à deux grandes conférences pour investisseurs en mai 2025. Le Directeur Financier de la société, Jason K. Garland, représentera Repligen lors de :
1. RBC Capital Markets' 2025 Global Healthcare Conference à New York (20-21 mai), avec une discussion animée par des analystes le 20 mai à 15h35 ET
2. Craig-Hallum's 22nd Annual Institutional Investor Conference à Minneapolis (28 mai)
Les deux événements incluront des rencontres individuelles avec des investisseurs. La présentation lors de la conférence RBC sera disponible en webdiffusion en direct sur le site des Relations Investisseurs de Repligen.
Repligen Corporation (NASDAQ:RGEN), ein führendes Unternehmen im Bereich Bioprozess-Technologie in den Lebenswissenschaften, hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Mai 2025 angekündigt. Der Finanzvorstand des Unternehmens, Jason K. Garland, wird Repligen vertreten bei:
1. RBC Capital Markets' 2025 Global Healthcare Conference in New York (20.-21. Mai), mit einer von Analysten geleiteten Diskussion am 20. Mai um 15:35 Uhr ET
2. Craig-Hallums 22. jährliche Institutionelle Investorenkonferenz in Minneapolis (28. Mai)
Beide Veranstaltungen umfassen Einzelgespräche mit Investoren. Die Präsentation auf der RBC-Konferenz wird per Live-Webcast auf der Investor-Relations-Website von Repligen verfügbar sein.
- None.
- None.
WALTHAM, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences.
- RBC Capital Markets’ 2025 Global Healthcare Conference, being held in New York on May 20-21. Jason K. Garland, Chief Financial Officer, is scheduled to participate in an analyst-led discussion on May 20 at 3:35 p.m. ET, in addition to a series of one-on-one meetings with investors.
- Craig-Hallum’s 22nd Annual Institutional Investor Conference, being held in Minneapolis on May 28. Jason K. Garland, Chief Financial Officer will participate in a series of one-on-one meetings with investors.
A live webcast of the RBC conference presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at www.repligen.com, and follow us on LinkedIn.
Repligen Contact:
Jacob Johnson
VP, Investor Relations
(781) 419-0204
investors@repligen.com
FAQ
When is Repligen (RGEN) presenting at the RBC Capital Markets Healthcare Conference 2025?
How can I watch Repligen's (RGEN) presentation at the RBC Healthcare Conference?
Which conferences will Repligen (RGEN) attend in May 2025?
Who will represent Repligen (RGEN) at the May 2025 investor conferences?
